yuchang li | Chinese Medicine | Best Researcher Award

Posted on by Pencis

Mr. yuchang li | Chinese Medicine | Best Researcher Award

Shanxi University of Chinese Medicine | China

AUTHOR PROFILE

ORCID ID

🎓 EARLY ACADEMIC PURSUITS

Yu-chang Li is currently a student at Shanxi University of Chinese Medicine, enrolled in the Third Clinical College of Clinical Medicine, specializing in Traditional Chinese and Western Medicine. From an early stage in his academic journey, he has demonstrated a strong passion for integrating traditional Chinese medicine (TCM) with modern medical approaches. His commitment to research and academic excellence has been recognized through numerous awards and publications.

🏆 PROFESSIONAL ENDEAVORS

Yu-chang Li has made significant contributions to medical research, particularly in the field of oncology alternative medicine. His work bridges the gap between traditional Chinese medicine and Western medical practices, exploring innovative therapeutic approaches to combat life-threatening diseases.

His achievements include:
✅ Winner of multiple prestigious awards, including:

  • National Silver Award at the 10th National College Students Basic Medical Innovation Research and Experimental Design Forum
  • Provincial Silver Award
  • Provincial Bronze Award

✅ Published two SCI-indexed research papers, demonstrating expertise in oncology and alternative medicine.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON CHINESE MEDICINE

Yu-chang Li’s research is centered on the role of Chinese herbal medicine in oncology, with a particular focus on the immunomodulatory effects of Astragalus membranaceus (Huangqi) and other herbal formulations.

🔹 Astragalus Injection and Osteosarcoma
One of his landmark studies, Astragalus Injection Inhibits the Growth of Osteosarcoma by Activating Cytotoxic T Lymphocyte and Targeting CTSL, investigates the use of Huangqi Injection (HQI) in treating osteosarcoma. His research highlights the immunomodulatory potential of HQI, demonstrating that its active component, Cycloastragenol (CG), enhances immune response and targets CTSL, leading to tumor suppression.

🔹 Shenqi Granules and Cerebral Ischemia-Reperfusion Injury
In another study, Shenqi Granules Enhance Recovery from Cerebral Ischemia-Reperfusion Injury by Modulating Tryptophan and Tyrosine Metabolism and Activating NFE2L2/NRF2, he explores the neuroprotective effects of Shenqi granules. His findings contribute to stroke rehabilitation research, emphasizing the potential of herbal formulations in neurological recovery.

His research provides scientific validation for traditional Chinese medicine (TCM) therapies, paving the way for their integration into modern medical treatments.

🌍 IMPACT AND INFLUENCE

Yu-chang Li’s research has had a profound impact on both oncology and alternative medicine by:
📌 Advancing integrative medicine through scientific validation of herbal treatments.
📌 Contributing to cancer immunotherapy using TCM-based approaches.
📌 Providing new perspectives on the treatment of osteosarcoma and stroke recovery.
📌 Inspiring future researchers to explore synergistic applications of Chinese and Western medicine.

📖 ACADEMIC CITATIONS AND RECOGNITION

As a young scholar, Yu-chang Li’s publications have gained recognition in the scientific community, contributing valuable insights to the fields of Chinese medicine and oncology. His work is frequently cited by researchers investigating herbal immunotherapy, oncology treatments, and neuroprotection strategies.

🔮 LEGACY AND FUTURE CONTRIBUTIONS

Yu-chang Li is poised to become a leading figure in integrative medicine, focusing on oncology and alternative therapies. His future contributions may include:
✨ Developing new herbal formulations for cancer treatment.
✨ Conducting clinical trials to further validate TCM therapies.
✨ Bridging the gap between traditional and modern medicine.
✨ Expanding the global acceptance of TCM in cancer care.

His research and innovations will undoubtedly shape the future of medicine, providing safe, effective, and scientifically backed treatments that integrate the wisdom of traditional Chinese medicine with modern scientific advancements.

🌍CONCLUSION 

Yu-chang Li is a rising scholar in integrative medicine, dedicated to advancing the scientific understanding of Traditional Chinese Medicine (TCM) and its applications in oncology and neurological disorders. His research on Astragalus Injection in osteosarcoma and Shenqi granules in stroke recovery showcases the therapeutic potential of herbal medicine, reinforcing the importance of evidence-based alternative treatments.

 

📊🔬NOTABLE PUBLICATION:
  • Title: Shenqi granules enhance recovery from cerebral ischemia-reperfusion injury by modulating tryptophan and tyrosine metabolism and activating NFE2L2/NRF2.
    Authors: Liu HX, Yang MK, Li YC, Liu CX, Li GP, Meng XL, Pei K, Wen SY
    Journal: International Journal of Phytotherapy and Phytopharmacology
    Year: 2025

 

  • Title: Astragalus injection inhibits the growth of osteosarcoma by activating cytotoxic T lymphocyte and targeting CTSL.
    Authors: Liu HX, Li YC, Su RB, Liu CX, Wen SY.
    Journal: Journal of Ethnopharmacology
    Year: 2025

Dr. Ohidul Alam | Oncology Case Reports | Best Researcher Award

Posted on by Pencis

Dr. Ohidul Alam | Oncology Case Reports | Best Researcher Award

Jiangsu University | China

Author Profile

Scopus

Google Scholar

🌍 Dr. Ohidul Alam: Postdoctoral Research Fellow and Environmental Innovator 🌱

💧Current Position

  • Postdoctoral Research Fellow, Institute of Environment and Ecology, School of the Environment and Safety Engineering, Jiangsu University

♻️Research Focus

Dr. Ohidul Alam is dedicated to advancing environmental sustainability and ecological safety. His primary research interests include:

  • 🌊 Coastal Environment and Wetlands: Investigating microplastics as vectors for antibiotic resistance genes (ARGs) and heavy metals.
  • ♻️ Hazardous Waste Management: Treatment and recycling of waste and heavy metals.
  • 💧 Wastewater Treatment and Pollution Control: Developing advanced environmental materials like adsorbents and composites for energy storage and purification.
  • 🧬 Antibiotic Resistance Genes: Exploring ARG mechanisms in ecological systems.

🎓Education 

  • PhD in Environmental Engineering, East China University of Science and Technology, Shanghai, China (2016–2021)
  • MEng in Environmental Engineering, UNEP-Tongji Institute of Environment for Sustainable Development, Tongji University, Shanghai, China (2014–2016)
  • MS in Environmental Science, Institute of Forestry and Environmental Sciences, University of Chittagong, Bangladesh (2010–2011)

🛠Career Snapshot 

  • Postdoctoral Research (2023–Present): Investigating microplastics as vehicles for ARGs and toxic heavy metals in coastal wetlands, assessing ecological and health risks.
  • Environmental Officer (2022–2023): Sustainable Enterprise Project (SEP), Integrated Development Foundation (IDF).
  • Research Associate and Assistant: Contributed to seven major academic and socio-environmental projects.

🖋Publications and Contributions 

  • Published 15 SCI-indexed journal papers, 9 international open-access journal articles, and 13 international conference papers.
  • Authored 3 national journal articles and 3 technical/working papers.
  • Supported colleagues in research, thesis writing, and scientific publications.

🏆Recognition and Awards 

  • Chinese Scholarship Council (CSC) and Marine Scholarship of China (MSC), 2014
  • Tongji University President Scholarship (2nd Prize), 2015, for academic excellence.

🤝Professional Memberships 

  • International Waste Working Group (IWWG)
  • Human Development Foundation (HDF)

🧾Reviewer Roles 

  • Journal of Environmental Management
  • Environmental Research
  • Environment, Development and Sustainability
  • Water Science and Technology

📚Training and Skills Development 

  • Completed advanced training on the Leaching Environmental Assessment Framework (LEAF) for waste treatment and beneficial reuse.

Dr. Alam’s interdisciplinary approach bridges the gap between environmental engineering, sustainable development, and ecological safety. His work continues to inspire progress toward a cleaner, safer world. 🌍✨

🌏 CONCLUSION

Dr. Ohidul Alam exemplifies dedication to environmental sustainability through his groundbreaking research on hazardous waste management, pollution control, and ecological risks posed by microplastics. His extensive academic achievements, impactful publications, and hands-on contributions to global environmental projects highlight his expertise and commitment to creating sustainable solutions for pressing environmental challenges. As a scholar, innovator, and mentor, Dr. Alam continues to pave the way for a cleaner, safer, and more sustainable future. 🌱🌍

📊🔬NOTABLE PUBLICATION:
  • Title: An in-depth review on municipal solid waste management, treatment, and disposal in Bangladesh
    • Authors: Alam, O.; Qiao, X.
    • Journal: Sustainable Cities and Society
    • Year: 2020

 

  • Title: A preliminary life cycle assessment on healthcare waste management in Chittagong City, Bangladesh
    • Authors: Alam, O.; Mosharraf, A.
    • Journal: International Journal of Environmental Science and Technology
    • Year: 2020

 

  • Title: Influences of chemically controlled Ca-bearing minerals in chitosan on Pb²⁺ removal efficiency
    • Authors: Alam, O.; Qiao, X.
    • Journal: Journal of Environmental Health Science and Engineering
    • Year: 2020

 

  • Title: The effect of Ca-bearing contents in chitosan on Pb²⁺, Cd²⁺, and Cu²⁺ adsorption and its adsorption mechanism
    • Authors: Alam, O.; Qiao, X.; Nath, T.K.
    • Journal: Journal of Environmental Health Science and Engineering
    • Year: 2020

 

  • Title: Remediation of heavy metals polluted soil environment: A critical review on biological approaches
    • Authors: Zheng, X.; Lin, H.; Du, D.; Jiang, S.; Li, J.
    • Journal: Ecotoxicology and Environmental Safety
    • Year: 2024

Assoc Prof Dr. Haruto Nishida | Breast Cancer Immunity | Best Researcher Award

Posted on by Pencis

Assoc Prof Dr. Haruto Nishida | Breast Cancer Immunity | Best Researcher Award

Faculty of Medicine, Oita University | Japan

Author Profile

Scopus

🧬 Dr. Haruto Nishida, M.D., Ph.D. – Associate Professor of Diagnostic Pathology

Haruto Nishida, M.D., Ph.D., is an Associate Professor at the Department of Diagnostic Pathology at Oita University Hospital, Japan, where he has served in this role since April 2021. Dr. Nishida has a profound expertise in pathology, with a particular focus on diagnostic pathology, cytology, and molecular pathology.

🎓 Education and Early Career

Dr. Nishida earned his Medical Degree from the Faculty of Medicine at Oita University in 2009. He furthered his academic journey by obtaining a Ph.D. from the same institution in 2015, specializing in pathology. His post-graduate training includes a residency in General Medicine at Oita Medical Hospital and a fellowship in Diagnostic Pathology at Oita University.

🩺 Professional Experience

Dr. Nishida’s career at Oita University has been marked by progressive roles. Starting as an Assistant Professor in 2012, he was promoted to Lecturer in 2019 and then to Associate Professor in 2020. He continued in this role when he transitioned to Oita University Hospital in 2021, where he currently leads efforts in diagnostic pathology.

🏅 Board Certifications and Licensure

Dr. Nishida holds multiple prestigious board certifications, including the Japanese Board Certification in Pathology, Autopsy, Cytology, and Molecular Pathology. He earned his National Board of Medicine license in 2009, showcasing his dedication to the field.

🌍 Professional Affiliations

Dr. Nishida is an active member of several professional organizations, both in Japan and internationally. He is involved with the Japanese Society of Pathology, Japanese Society of Clinical Cytology, Japan Dermatopathology Society, and the Bone and Soft Tissue Tumor Club of Japan. Additionally, he is a member of the United States and Canadian Academy of Pathology (USCAP) and the International Academy of Cytology.

Dr. Nishida’s contributions to the field of pathology, combined with his ongoing research and teaching, make him a distinguished figure in diagnostic pathology.

🚀 Conclusion

In summary, Dr. Haruto Nishida is a highly accomplished pathologist whose extensive expertise and dedication to diagnostic pathology have significantly contributed to the field. His career, marked by a progression of academic and clinical roles at Oita University, is underpinned by his strong educational background and numerous board certifications. As an active member of both national and international professional organizations, Dr. Nishida continues to impact the field through his research, teaching, and clinical work. His ongoing commitment to excellence in pathology makes him a respected leader in the medical community.

 

📊🔬NOTABLE PUBLICATION:

 

  • SOX10-Internal Tandem Duplications and PLAG1 or HMGA2 Fusions Segregate Eccrine-Type and Apocrine-Type Cutaneous Mixed Tumors
    Authors: Macagno, N., Kervarrec, T., Thanguturi, S., De la Fouchardière, A., Battistella, M.
    Journal: Modern Pathology
    Year: 2024

 

  • Recurrent Cardiac Tamponade Following Coronavirus Disease 2019 mRNA Vaccination: A Case Report
    Authors: Kaimori, R., Nishida, H., Yahiro, T., Iwami, T., Daa, T.
  • Journal: Cardiovascular Pathology
    Year: 2024

 

  • Lipid Droplet Detection in Histopathological Images Using Reinforcement Learning
    Authors: Harada, Y., Nishida, H., Matsuura, K.
    Journal: Biotechnology and Biotechnological Equipment
    Year: 2024

 

  • Right Atrial Cardiac Myxoma with Malignant Transformation to Undifferentiated Sarcoma: A Case Report
    Authors: Kaimori, R., Nishida, H., Oyama, Y., Kawamura, K., Daa, T.
    Journal: Cardiovascular Pathology
    Year: 2024

 

  • The Relationship Between Tumor Immunity and the cGAS–STING Pathway in Breast Cancer: An Immunohistochemical Study
    Authors: Nishida, H., Ohara, N., Kato, A., Kawamura, K., Daa, T.
    Journal: Experimental and Molecular Pathology
    Year: 2024